These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29480231)

  • 1. Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.
    König A; Vicente Miranda H; Outeiro TF
    J Parkinsons Dis; 2018; 8(1):33-43. PubMed ID: 29480231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.
    Brings S; Fleming T; Freichel M; Muckenthaler MU; Herzig S; Nawroth PP
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary glycation compounds - implications for human health.
    Hellwig M; Diel P; Eisenbrand G; Grune T; Guth S; Henle T; Humpf HU; Joost HG; Marko D; Raupbach J; Roth A; Vieths S; Mally A
    Crit Rev Toxicol; 2024 Sep; 54(8):485-617. PubMed ID: 39150724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions.
    Gelain DP; Bittencourt RR; Bastos Mendes LF; Moreira JCF; Outeiro TF
    J Parkinsons Dis; 2023; 13(5):717-728. PubMed ID: 37270812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenfuro®-mediated arrest in the formation of protein-methyl glyoxal adducts: a new dimension in the anti-hyperglycemic potential of a novel fenugreek seed extract.
    Prosad Banik S; Kumar P; Bagchi D; Paul S; Goel A; Bagchi M; Chakraborty S
    Toxicol Mech Methods; 2024 Oct; 34(8):877-885. PubMed ID: 38832450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.
    Guerrero E; Vasudevaraju P; Hegde ML; Britton GB; Rao KS
    Mol Neurobiol; 2013 Apr; 47(2):525-36. PubMed ID: 22923367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.
    Salahuddin P; Rabbani G; Khan RH
    Cell Mol Biol Lett; 2014 Sep; 19(3):407-37. PubMed ID: 25141979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments.
    Bosbach C; Gatzemeier LM; Bloch von Blottnitz KI; König A; Diederichsen U; Steinem C; Outeiro TF
    Org Biomol Chem; 2024 Mar; 22(13):2670-2676. PubMed ID: 38483440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin inhibition of glycation processes.
    Beisswenger P; Ruggiero-Lopez D
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S95-103. PubMed ID: 14502106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats.
    Babu PV; Sabitha KE; Srinivasan P; Shyamaladevi CS
    Pharmacol Res; 2007 May; 55(5):433-40. PubMed ID: 17336542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling new secrets in Parkinson's disease: The glycatome.
    Chegão A; Vicente Miranda H
    Behav Brain Res; 2023 Mar; 442():114309. PubMed ID: 36706808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into the Effect of Methylglyoxal on the Conformation, Function, and Aggregation Propensity of α-Synuclein.
    Mariño L; Belén Uceda A; Leal F; Adrover M
    Chemistry; 2024 Jun; 30(36):e202400890. PubMed ID: 38687053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycation in Parkinson's disease and Alzheimer's disease.
    Vicente Miranda H; El-Agnaf OM; Outeiro TF
    Mov Disord; 2016 Jun; 31(6):782-90. PubMed ID: 26946341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?
    Münch G; Lüth HJ; Wong A; Arendt T; Hirsch E; Ravid R; Riederer P
    J Chem Neuroanat; 2000 Dec; 20(3-4):253-7. PubMed ID: 11207423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-enzymatic glycation of proteins: from diabetes to cancer].
    Ansari NA; Rasheed Z
    Biomed Khim; 2010; 56(2):168-78. PubMed ID: 21341505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylglyoxal-induced modification of myoglobin: An insight into glycation mediated protein aggregation.
    Banerjee S
    Vitam Horm; 2024; 125():31-46. PubMed ID: 38997168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting advanced glycation with pharmaceutical agents: where are we now?
    Borg DJ; Forbes JM
    Glycoconj J; 2016 Aug; 33(4):653-70. PubMed ID: 27392438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention.
    Brás IC; König A; Outeiro TF
    J Huntingtons Dis; 2019; 8(3):245-256. PubMed ID: 31322580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting α-synuclein post-translational modifications in Parkinson's disease.
    Canever JB; Soares ES; de Avelar NCP; Cimarosti HI
    Behav Brain Res; 2023 Feb; 439():114204. PubMed ID: 36372243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.